TRIMOPTIN

This brand name is authorized in Ireland

Active ingredients

The drug TRIMOPTIN contains one active pharmaceutical ingredient (API):

1 Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM

Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. Read about Trimethoprim

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRIMOPTIN Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01EA01	Trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EA Trimethoprim and derivatives
Discover more medicines within J01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IE	Health Products Regulatory Authority	Identifier(s): 49317, 49390